Metabolism in dogs of the chloro- and trifluoromethyl-analogues of a piperazine-substituted dihydrobenzoxazepine.
D000818:Animals; D001646:Bile / Q000378:metabolism; D001711:Biotransformation; D001923:Brain Chemistry; D002250:Carbon Radioisotopes; D002855:Chromatography, Thin Layer; D003989:Dibenzoxazepines / Q000097:blood / Q000378:metabolism* / Q000652:urine; D004285:Dogs; D000431:Ethanol / Q000097:blood / Q000378:metabolism / Q000652:urine; D005123:Eye / Q000378:metabolism; D005243:Feces / Q000032:analysis; D005965:Glucuronates / Q000378:metabolism; D005966:Glucuronidase; D006213:Hallucinogens / Q000097:blood / Q000378:metabolism* / Q000652:urine; D007700:Kinetics; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008297:Male; D013058:Mass Spectrometry; D009928:Organ Specificity; D010879:Piperazines / Q000097:blood / Q000378:metabolism / Q000652:urine; D013429:Sulfatases
D002250:Carbon Radioisotopes; D003989:Dibenzoxazepines; D005965:Glucuronates; D006213:Hallucinogens; D010879:Piperazines; D000431:Ethanol; D013429:Sulfatases; D005966:Glucuronidase